Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk

NCT06557057 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06557057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06557057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
November 16, 2023
Completion date
December 1, 2026
Enrollment
81 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

her2-positive breast carcinoma